Emerging Microbes & Infections (2017) 6, e60; doi:10.1038/emi.2017.50 www.nature.com/emi

CORRIGENDUM

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein Yingzhu Chen1,2, Shuai Lu2, Hao Jia1,2, Yao Deng2, Jianfang Zhou2, Baoying Huang2, Yueyang Yu2, Jiaming Lan2, Wenling Wang2, Yongliang Lou1, Kun Qin2 and Wenjie Tan1,2 Emerging Microbes & Infections (2017) 6, e60; doi:10.1038/emi.2017.50; published online 28 June 2017 Correction to: Emerging Microbes & Infections (2017) 6, e37; doi:10.1038/emi.2017.18; published online 24 May 2017 The authors apologize for an error in the first affiliation. The original affiliation ‘School of Laboratory Medicine and Life Science and Key Laboratory of Medical Virology, Wenzhou 325035, China’ should be changed to: ‘School of Laboratory Medicine and Life Science, Institute of Medical Virology, Wenzhou Medical University, Wenzhou 325035, China’.

1 School of Laboratory Medicine and Life Science, Institute of Medical Virology, Wenzhou Medical University, Wenzhou 325035, China and 2Key Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing 102206, China Correspondence: K Qin; WJ Tan E-mail: [email protected]; [email protected] Received 30 May 2017; accepted 30 May 2017

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein.

This corrects the article DOI: 10.1038/emi.2017.18...
42KB Sizes 0 Downloads 14 Views